Investigation of the mechanism of hypertension caused by BTKi in the treatment of hematologic diseases

Bruton’s tyrosine kinase inhibitors (BTKis) have made substantial impacts on the treatment of B-cell malignancies like chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Therapeutic benefits aside, the clinical use of BTKis comes with several side effects, of which hypertension...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jiayi Xu, Junling Lin, Haojian Gan, Qingjian He, WenJuan Wang, Yuanhua Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2025-05-01
Colecção:	Frontiers in Pharmacology
Assuntos:	BTKi ibrutinib oxidative stress hypertension cardiovascular diseases
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1585061/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!